The Novo Nordisk Foundation and the Export and Investment Fund of Denmark (EIFO) are pleased to announce the appointment of Nadia Carlsten as CEO of Danish Centre for AI Innovation A/S (DCAI), a company which will own and run Denmark’s first AI supercomputer, Gefion. The public-private initiative to build Gefion in collaboration with NVIDIA, was […]
Leading scientists, philanthropists, and policymakers from around the world are coming together in Denmark at the Global Science Summit, hosted by the Novo Nordisk Foundation as part of the organisation’s 100-year anniversary. The goal is to explore the interaction between the world’s biggest health and sustainability challenges and pave the way for new scientific breakthroughs. […]
COPENHAGEN, Denmark, Jan. 9, 2024 – The Novo Nordisk Foundation is committing up to USD 25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this […]
The Novo Nordisk Foundation has committed up to DKK 950 million (EUR 127 million) to establish a world-class facility for the final development steps and upscaling of cell therapies for testing in humans. The Novo Nordisk Foundation Cellerator will fill a critical gap in the Danish cell therapy ecosystem, helping to translate breakthroughs in cell […]
